Cns Metastases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-02-13
Clinical Trial Update: 131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases [Phase 2, Phase 3]
Clinical trial update for 131I-omburtamab in neuroblastoma with CNS/leptomeningeal metastases shows terminated status with results posted.